Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug ...

GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...

Musk’s push for affordable GLP-1 medications comes as lawmakers on both sides have sought expanded coverage for weight loss ...

From Philly and the Pa. suburbs to South Jersey and Delaware, what would you like WHYY News to cover? While there are some state and federal efforts to expand insurance coverage for these drugs in ...

The best Medicare Supplement ... and savings on vitamins and weight loss programs. For an added cost, you can get prescription drug, dental, or vision coverage. Customers made roughly the number ...

Connecticut law requires Medicaid to cover certain weight loss drugs, but officials say it hasn't been happening due to cost ...

The growing popularity of GLP-1 receptor agonists—including Ozempic and Wegovy from Novo Nordisk, and Mounjaro and Zepbound ...

Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration ...

The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive sleep ...